Welcome to LookChem.com Sign In|Join Free

CAS

  • or

301666-04-6

Post Buying Request

301666-04-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

301666-04-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 301666-04-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,1,6,6 and 6 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 301666-04:
(8*3)+(7*0)+(6*1)+(5*6)+(4*6)+(3*6)+(2*0)+(1*4)=106
106 % 10 = 6
So 301666-04-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO3/c1-3-14-10(12)8-6-7(11)4-5-9(8)13-2/h4-6H,3,11H2,1-2H3

301666-04-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 5-amino-2-methoxybenzoate

1.2 Other means of identification

Product number -
Other names 2-Thiophenecarboxylicacid,3-amino-5-phenyl-,ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:301666-04-6 SDS

301666-04-6Downstream Products

301666-04-6Relevant articles and documents

HETEROCYCLIC ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS

-

Page/Page column 81, (2010/10/19)

The present invention is directed to compounds which are potentiators of metabotropic glutamate receptors, including the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 301666-04-6